Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma.
Transplantation
; 101(5): 1001-1008, 2017 05.
Article
in En
| MEDLINE
| ID: mdl-27926593
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Liver Transplantation
/
Cost-Benefit Analysis
/
Carcinoma, Hepatocellular
/
Hepatitis C, Chronic
/
Liver Cirrhosis
/
Liver Neoplasms
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Transplantation
Year:
2017
Document type:
Article
Affiliation country:
Canada
Country of publication:
United States